The endothelium in cerebral malaria: Both a target cell and a major player

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 1303-1310

  Combes, Valéry ^a   Grau, Georges E ^a   Lou, Jin Ning ^b  

^a University of Sydney   (Australia)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856830690     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.143     Document Type: Chapter

References (85)

1. Rogerson SJ, Grau GE, Hunt NH. The microcirculation in severe malaria. Microcirculation. 2004;11(7):559-576.
2. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malariaa neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res. 2004;1:91-110.
3. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998;79(1):1-53.
4. Taylor WR, White NJ. Malaria and the lung. Clin Chest Med. 2002;23(2):457-468.
5. Eiam-Ong S. Malarial nephropathy. Semin Nephrol. 2003;23(1): 21-33.
6. Marchiafava E, Bignami E. Malaria. In: Stedman TL, ed. Twen-tieth Century Practice of Medicine: An International Encyclopedia of Modern Medical Science. New York: William Wood & Co.; 1900:227-252.
7. Oh SS, Chishti AH, Palek J, Liu SC. Erythrocyte membrane alter-ations in Plasmodium falciparum malaria sequestration. Curr OpinHematol. 1997;4(2):148-154.
8. Sharma YD. Knob proteins in falciparum malaria. Indian J Med Res. 1997;106:53-62.
9. Pasloske BL, Howard RJ. Malaria, the red cell, and the endothe-lium. Annu Rev Med. 1994;45:283-295.
10. Hasler T, Handunnetti SM, Aguiar JC, et al. In vitro rosetting, cytoadherence, and microagglutination properties of Plasmod-ium falciparum-infected erythrocytes from Gambian and Tanza-nian patients. Blood. 1990;76(9):1845-1852.
11. Aikawa M, Iseki M, Barnwell JW, et al. The pathology of human cerebral malaria. Am J Trop Med Hyg. 1990;43(2 Pt 2):30-37.
12. Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neu-rosurg Psychiatr. 2000;69(4):433-441.
13. Newton CR, Taylor TE, Whitten RO. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg. 1998; 58(5):673-683.
14. Spitz S. The pathology of acute falciparum malaria. Mil Surg. 1946;99:555-572.
15. MacPherson GG, Warrell MJ, White NJ, et al. Human cerebral malaria. A quantitative ultrastructural analysis ofparasitized ery-throcyte sequestration. Am J Pathol. 1985;119(3):385-401.
16. Aikawa M. Human cerebral malaria. Am J Trop Med Hyg. 1988; 39(1):3-10.
17. Lemercier G, Rey M, Collomb H. Cerebral lesions of malaria in children. Bull Soc Pathol Exot Filiales. 1966;59(4):533-548.
18. Thomas JD. Clinical and histopathological correlation of cerebral malaria. Trop GeogrMed. 1971;23(3):232-238.
19. Boonpucknavig V, Boonpucknavig S, Udomsangpetch R, Nitiya-nant P. An immunofluorescence study of cerebral malaria. A correlation with histopathology. Arch PatholLabMed. 1990;114(10): 1028-1034.
20. Turner G. Cerebral malaria. Brain Pathol. 1997;7(1):569-582.
21. Edington GM. Cerebral malaria in the Gold Coast African: four autopsy reports. Ann Trop Med Parasitol. 1954;48(3):300-306.
22. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med. 2004;10(2):143-145.
23. Turner GD, Ly VC, Nguyen TH, et al. Systemic endothelial acti-vation occurs in both mild and severe malaria. Correlating der-mal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol. 1998; 152(6):1477-1487.
24. Berendt AR, Turner GDH, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994;10:412-414.
25. Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today. 1994;10:410-412.
26. Grau GE, de Kossodo S. Cerebral malaria: Mediators, mechanical obstruction or more? Parasitol Today. 1994;10:408-409.
27. Maegraith BG. Comments on pathophysiology. Mil Med. 1966; 131(9):S1111-S1114.
28. Maegraith B, Fletcher A. The pathogenesis of mammalian malaria. Adv Parasitol. 1972;10:49-75.
29. Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001;14(4):810-820.
30. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003;99(2):221-260.
31. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24(9): 491-499.
32. Turner GD, Morrison H, Jones M, et al. An immunohisto-chemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for inter-cellular adhesion molecule-1 in cerebral sequestration. Am J Pathol. 1994;145(5):1057-1069.
33. Grau GE, Pointaire P, Piguet PF, et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol. 1991;21(9): 2265-2267.
34. Grau GE, Tacchini-Cottier F, Vesin C, et al. TNF-induced microvascular pathology: active role for platelets and importance ofthe LFA-1/ICAM-1 interaction. Eur Cytokine Netw. 1993;4(6): 415-419.
35. Grau GE, Fajardo LF, Piguet PF, et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 1987;237(4819):1210-1212.
36. Clark IA, Cowden WB, Butcher GA, Hunt NH. Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol. 1987;129(1):192-199.
37. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989;320(24):1586-1591.
38. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmod-ium falciparum malaria. Lancet. 1990;336(8725):1201-1204.
39. Kern P, Hemmer CJ, Van Damme J, et al. Elevated tumor necro-sis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989; 87(2):139-143.
40. Butcher GA, Garland T, Ajdukiewicz AB, Clark IA. Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands. Trans R Soc Trop Med Hyg. 1990;84(5):658-661.
41. van Hensbroek MB, Palmer A, Onyiorah E, et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis. 1996;174(5):1091-1097.
42. Engwerda CR, Mynott TL, Sawhney S, et al. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 2002;195(10):1371-1377.
43. Clark IA, Gray KM, Rockett EJ, et al. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans R Soc Trop Med Hyg. 1992;86(6):602-607.
44. de Kossodo S, Grau GE. Profiles of cytokine production in relation with susceptibility to experimental cerebral malaria. J Immunol. 1993;151:4811-4820.
45. Eckwalanga M, Marussig M, Tavares MD, et al. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci USA. 1994;91(17):8097-8101.
46. Kossodo S, Monso C, Juillard P, et al. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology. 1997;91(4):536-540.
47. Omer FM, Riley EM. Transforming growth factor beta produc-tion is inversely correlated with severity of murine malaria infection. J Exp Med. 1998;188(1):39-48.
48. Artavanis-Tsakonas K, Tongren JE, Riley EM. The war between the malaria parasite and the immune system: immunity, immu-noregulation and immunopathology. Clin Exp Immunol. 2003; 133(2):145-152.
49. Wenisch C, Parschalk B, Narzt E, et al. Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falci-parum malaria. Clin Immunol Immunopathol. 1995;74(1):115-117.
50. Ho M, Sexton MM, Tongtawe P, et al. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lym-phoproliferation in acute Plasmodium falciparum malaria. J Infect Dis. 1995;172(3):838-844.
51. Ho M, Schollaardt T, Snape S, et al. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J Infect Dis. 1998;178(2):520-525.
52. Clark IA, Ilschner S, MacMicking JD, Cowden WB. TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol Lett. 1990;25(1-3):195-198.
53. Kurtzhals JA, Adabayeri V, Goka BQ, et al. Low plasma con-centrations of interleukin 10 in severe malarial anaemia com-pared with cerebral and uncomplicated malaria. Lancet. 1998; 351(9118):1768-1772.
54. Winkler S, Willheim M, Baier K, et al. Reciprocal regulation of Th1-and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun. 1998;66(12):6040-6044.
55. Brenier-Pinchart MP, Pelloux H, Derouich-Guergour D, Ambroise-Thomas P. Chemokines in host-protozoan-parasite interactions. Trends Parasitol. 2001;17(6):292-296.
56. Burgmann H, Hollenstein U, Wenisch C, et al. Serum concen-trations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol. 1995;76(1 Pt 1):32-36.
57. Friedland JS, Ho M, Remick DG, et al. Interleukin-8 and Plas-modium falciparum malaria in Thailand. Trans R Soc Trop Med Hyg. 1993;87(1):54-55.
58. Filipovic R, Jakovcevski I, Zecevic N. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neu-rosci. 2003;25(2-4):279-290.
59. Strasly M, Cavallo F, Geuna M, et al. IL-12 inhibition ofendothe-lial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol. 2001;166(6):3890-3899.
60. Hviid L, Theander TG, Elhassan IM, Jensen JB. Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria. Immunol Lett. 1993;36(1):51-58.
61. Boehme MW, Werle E, Kommerell B, Raeth U. Serum levels of adhesion molecules andthrombomodulin as indicators ofvascu-lar injury in severe Plasmodium falciparum malaria. Clin Investig. 1994;72(8):598-603.
62. Jakobsen PH, Morris-Jones S, Ronn A, et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology. 1994;83(4):665-669.
63. Combes V, Taylor TE, Juhan-Vague I, et al. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA. 2004;291 (21):2542-2544.
64. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999; 104(1):93-102.
65. Hommel M. Amplification ofcytoadherence in cerebral malaria: towards a more rational explanation of disease pathophysiology. Ann Trop Med Parasitol. 1993;87(6):627-635.
66. Lou J, Gasche Y, Zheng L, et al. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic sus-ceptibility to cerebral malaria. Eur J Immunol. 1998;28(12):3989-4000.
67. Monso-Hinard C, Lou JN, Behr C, et al. Expression of major his-tocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Immunology. 1997;92(1):53-59.
68. Chen Q, Schlichtherle M, Wahlgren M. Molecular aspects of severe malaria. Clin Microbiol Rev. 2000;13(3):439-450.
69. Favre N, Da Laperousaz C, Ryffel B, et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999;1(12):961-968.
70. Combes V, Rosenkranz AR, Redard M, et al. Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am J Pathol. 2004;164(3):781-786.
71. Lucas R, Juillard P, Decoster E, et al. Crucial role oftumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol. 1997;27(7):1719-1725.
72. Stoelcker B, Hehlgans T, Weigl K, et al. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect Immun. 2002;70(10):5857-5859.
73. Pino P, Vouldoukis I, Kolb JP, et al. Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J Infect Dis. 2003;187(8): 1283-1290.
74. Pino P, Vouldoukis I, Dugas N, et al. Induction of the CD23/nitric oxide pathway in endothelial cells downregulates ICAM-1 expression and decreases cytoadherence of Plasmodium falciparum-infected erythrocytes. Cell Microbiol. 2004;6(9): 839-848.
75. Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology. 1988;96(Pt 3):579-589.
76. Belnoue E, Kayibanda M, Vigario AM, et al. On the pathogenic role ofbrain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002;169(11):6369-6375.
77. Grau GE, Piguet PF, Engers HD, et al. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol. 1986;137:2348-2354.
78. Roberts DJ, Pain A, Kai O, et al. Autoagglutination of malaria-infected red blood cells and malaria severity. Lancet. 2000;355 (9213):1427-1428.
79. Pain A, Ferguson DJ, Kai O, et al. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci USA. 2001;98(4):1805-1810.
80. Grau GE, Mackenzie CD, Carr RA, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis. 2003;187(3):461-466.
81. Wassmer SC, Lepolard C, Traore B, et al. Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhe-sion to activated endothelial cells. J Infect Dis. 2004;189(2): 180-189.
82. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis ofthe microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999;155(2):395-410.
83. Berendt AR, Ferguson DJ, Gardner J, et al. Molecular mecha-nisms of sequestration in malaria. Parasitology. 1994;108:S19-S28.
84. Lucas R, Grau GE, Matthay MA, Wendel A. Functional dissection of tumor necrosis factor in liver, brain and lungs. Curr Trends Immunol. 2002;4:47-59.
85. Wassmer SC, Combes V, Grau GE. Pathophysiology of cerebral malaria: role ofhost cells in the modulation ofcytoadhesion. Ann NY Acad Sci. 2003;992:30–38.